Published in Drug Week, November 25th, 2005
According to a study from the United States, "A scientific rationale is provided for estimating acceptable daily intake values (ADIs) for compounds with limited or no toxicity information to support pharmaceutical manufacturing operations. These ADIs are based on application of the 'thresholds of toxicological concern' (TTC) principle, in which levels of human exposure are estimated that pose no appreciable risk to human health."
"The same concept has...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.